Negative / Null Result ReportOpen accessMedicine· cited by 48

Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models

Jelena Jelicic; Karen Juul‐Jensen; Zoran Bukumirić; Michael Roost Clausen; Ahmed Ludvigsen Al‐Mashhadi; Robert Schou Pedersen; Christian Bjørn Poulsen; Peter de Nully Brown · 2023 · Blood Cancer Journal

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Currently, the International Prognostic Index (IPI) is the most used and reported model for prognostication in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). IPI-like variations have been proposed, but only a few have been validated in different populations (e.g., revised IPI (R-IPI), National Comprehensive Cancer Network IPI (NCCN-IPI)). We aimed to validate and compare different IPI-like variations to identify the model with the highest predictive accuracy for survival in newly diagnosed DLBCL patients. We included 5126 DLBCL patients treated with immunochemotherapy wit

Abstract by Jelena Jelicic; Karen Juul‐Jensen; Zoran Bukumirić; Michael Roost Clausen; Ahmed Ludvigsen Al‐Mashhadi; Robert Schou Pedersen; Christian Bjørn Poulsen; Peter de Nully Brown, Blood Cancer Journal (2023) — licensed CC BY 4.0.

Read the full paper (open access)